Takeda's Shire Acquisition Seen Opposed by Some Founding Family Members
Tokyo, Dec. 3 (Jiji Press)--Some members of the founding family of Takeda Pharmaceutical Co. <4502> have become opposed to the leading Japanese drug maker's plan to acquire Irish industry peer Shire PLC for roughly 7 trillion yen, a member of the family suggested Monday.
The Shire acquisition involves financial risks that are "too great" for "quite limited" benefits, founding family member and former senior Takeda official Kazuhisa Takeda, 78, told a press conference at the Foreign Correspondents' Club of Japan in Tokyo.
He, also a leading member of a group of former Takeda employees and current shareholders standing against the acquisition, noted that this view is shared by former Takeda President Kunio Takeda, 78.
The Japanese company aims to gain approval for the deal by winning at least two-thirds of voting rights in a vote at an extraordinary shareholders' meeting in Osaka on Wednesday.
The founding family owns less than 10 pct of all outstanding shares in Takeda.
[Copyright The Jiji Press, Ltd.]